ONCOSYNERGY, INC.
Biotechnology · STAMFORD, CT
BiotechnologySEC Form D
ONCOSYNERGY, INC. filed a Form D with the U.S. Securities and Exchange Commission on May 26, 2026, reporting $6,608,832 raised toward a $8,208,830 offering.
Incorporated in Delaware and based in STAMFORD, CT, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that ONCOSYNERGY, INC. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Allen SalmasiDirector
- Hen Suh ParkDirector
- Anne-Marie CarbonellExecutive Officer · Director
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$10.0MRaised